June 5, 2017 · STOCK Act disclosure
Representative James B. Renacci (Republican-OH) bought Karyopharm Therapeutics Inc., a stock transaction, valued at $1,000 - $15,000. The trade took place on June 5, 2017 and was disclosed on June 22, 2017 (owner: Self). Members of Congress must report such transactions within 45 days under the STOCK Act.